Studies on GDH, a key enzyme in glutamate metabolism, yielded inconsistent results. GDH activity was reported to be reduced in leucocytes, fibroblasts and muscle mitochondria of patients with multiple system atrophy disorders, including some cases presenting as "atypical ALS",'-0 but GDHactivity in leucocytes of typical ALS patients has been found to be normal,4 or decreased in a subgroup of patients." The specificity of the observations on GDH changes in leucocytes is doubtful since similar changes in GDH have been found in a variety of unrelated neurodegenerative disorders.'2 13 If changes in glutamate metabolism are relevant to the pathogenesis of ALS, it is important to establish whether the activity of GDH is altered in the central nervous system. We have therefore measured the activity of GDH and the concentrations of glutamate and other neurotransmitter amino acids in anatomically dissected (11) hours]. For measurements of aspartate, death-to-freezing intervals were matched (controls n = 9: 13 (2) hours; ALS n = 5: 14 (3) hours). Lumbar segments were obtained from six controls, three females and three males (mean age: 60 (5) years; mean post mortem delay 15 (2) hours) and four ALS patients, three females and one male (mean age: 60 (2) years; mean post mortem delay 15 (6) hours). Of five controls and three ALS patients both cervical and lumbar enlargements were available for study. Control patients had died of myocardial infarction (five patients), respiratory failure, carcinoma of the tonsils, carcinoma of the breast, leukaemia and melanoma. All ALS patients had died of respiratory failure. To our knowledge, none of the control patients had shown signs of neurological impairment. Seven ALS patients had been diagnosed by a neurologist as nonfamilial and one case as probably familial ALS following full clinical investigation. Histopathological examination excluded other causes of the neurological syndrome and showed depletion of anterior horn cells and 100 mM ADP (Sigma), 1A44 ml 70 mM triethanolamine hydrochloride (pH 8-0) plus 3,5 mM EDTA, 60 pl 3-3 M ammonium acetate and 300 y1 50 mM Na2HPO4 buffer (pH 7.5). Whole homogenates (0 1 ml, equivalent to 0-3-0-5 mg wet weight) were added and the reaction started by the addition of 0-06 ml 233 mM alpha-ketoglutarate to a final volume of 2-0 ml. The rate of oxidation of NADH at room temperature was measured with a Beckman spectrophotometer at 340 nm. All samples were done at least in duplicate. The assay was performed on the day of homogenisation, since storage of homogenates at -20°C overnight resulted in a variable loss of GDH activity. Pretreatment with Triton X 100 (0 05 and 01%) did not result in further activation of GDH. Enzyme activity appeared linear in tissue concentrations from 0.1-1 mg. Measurements in independent assays using adjacent tissue slices varied less than 10%. AMINO ACIDS For estimation of neurotransmitter amino acids, aliquots of 0-03 ml were diluted with 0-09 ml 0 05 M perchloric acid and centrifuged at 17000 x g for 15 minutes. In 20-40 ,l of supernatant, corresponding to 0-10-020 mg wet tissue, amino acids were analysed by means of high pressure liquid chromatography (HPLC) after post-column derivatisation by the fluorogenic reagent o-phthalaldehyde (OPT) as described by
Schmid et al."5 Protein was determined by
Lowry's method. '6 Mean values of the control and the ALS group were compared with Student's t test.
Results

GDH ACTIVITY
In cervical spinal cord ofneurologically normal controls, highest GDH activity was found in the ventral grey matter [2-17 (0-2) pmol/h/mg wet weight; mean (SEM) n = 10] followed by the dorsal horn (1-58 -009) (fig 2a) . In white Open bars: controls (n = 10 in cervical, n = 6 in lumbar spinal cord), hatched bars: ALS patients (n = 7 in cervical, n = 4 in lumbar spinal cord). *p < 0-02; **p < 001; ***p < 0-002 (Student's t test).
Abbreviations as infig 1. of Our investigation shows an increase in GDH activity in discrete anatomic subdivisions of cervical and lumbar spinal cord of ALS patients compared with non-neurological controls. Apart from an early histochemical study,'7 we are not aware of any previous reports on GDH activity in human spinal cord. Given the longer death-to-freezing interval in ALS cervical samples and the slight decrease in GDH activity with increasing post mortem delay (fig 3) , the amount of changes in enzyme activity in ALS is presumably underestimated. As we found no increase in GDH in the ventral grey matter, the reported changes are not likely to be due to tissue shrinkage. The total protein content in ALS was normal, suggesting that the increase in GDH is a specific change.
GDH is a mitochondrial enzyme that catalyses the inter-conversion of alphaketoglutarate and glutamate, connecting carbohydrate and amino acid metabolism.'8 It is thought to act mainly in the direction of glutamate synthesis and is thus likely to play an important role in ammonia fixation.8 19 Immunohistochemical studies suggests a collocalisation ofGDH and glial fibrillary acidic protein, a marker of astroglia cells. 202 
